Related Experiment Video
Updated: Nov 2, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Association of Sickle Cell Trait with Risk and Mortality of COVID-19: Results from the United Kingdom Biobank
W Kyle Resurreccion1, Joseph Hulsizer2, Zhuqing Shi1
11Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.
Insights
Black individuals with sickle cell trait (SCT) showed similar COVID-19 infection rates but higher mortality. SCT carriers with diabetes faced significantly increased COVID-19 mortality risk.
Area of Science:
- Genetics and Molecular Biology
- Immunology
- Epidemiology
Background:
- Sickle cell trait (SCT) involves inheriting one copy of the Glu6Val hemoglobin mutation, prevalent in Black populations (5-10%).
- Hemoglobin's role in immune function and observed disparities in COVID-19 severity among Black individuals warrant investigation into SCT's impact.
Purpose of the Study:
- To investigate the association between sickle cell trait and COVID-19 infection and mortality risk in Black individuals.
- To examine the specific risk of COVID-19 mortality among Black SCT carriers, particularly those with pre-existing diabetes.
Main Methods:
- Utilized data from the United Kingdom Biobank to analyze COVID-19 infection and mortality rates.
- Compared outcomes between Black individuals with SCT and non-carriers who underwent COVID-19 testing.
Main Results:
- Infection rates for COVID-19 were similar between Black SCT carriers (19.7%) and non-carriers (21.1%).
- COVID-19 mortality was higher in Black SCT carriers (28.6%) compared to non-carriers (12.6%), though not statistically significant (OR, 3.04; P=0.12).
- Black SCT carriers with diabetes exhibited a dramatically higher COVID-19 mortality rate (100%) than those without diabetes (0%; OR, 90.71; P=0.0005).
Conclusions:
- Black SCT carriers may face an elevated risk of COVID-19 mortality.
- The combination of sickle cell trait and pre-existing diabetes poses a disproportionately high risk for COVID-19 mortality in Black individuals.
- Further research with larger cohorts is recommended to confirm these findings.
Abstract:
Sickle cell trait (SCT) carriers inherit one copy of the Glu6Val mutation in the hemoglobin gene and is particularly common in Black individuals (5-10%). Considering the roles of hemoglobin in immune responses and the higher risk for coronavirus disease (COVID-19) among Black individuals, we tested whether Black SCT carriers were at increased risk for COVID-19 infection and mortality according to the United Kingdom Biobank. Among Black individuals who were tested for COVID-19, we found similar infection rates among SCT carriers (14/72; 19.7%) and noncarriers (167/791; 21.1%), but higher COVID-19 mortality rates among SCT carriers (4/14; 28.6%) than among noncarriers (21/167; 12.6%) (odds ratio [OR], 3.04; 95% confidence interval [CI], 0.69-11.82; P = 0.12). Notably, SCT carriers with preexisting diabetes had significantly higher COVID-19 mortality (4/4; 100%) than those without diabetes (0/10; 0%; (OR, 90.71; 95% CI, 5.66-infinite; P = 0.0005). These findings suggest that Black SCT carriers with preexisting diabetes are at disproportionally higher risk for COVID-19 mortality. Confirmation by larger studies is warranted.
Related Concept Videos
Multiple Allele Traits
Single Nucleotide Polymorphisms-SNPs
Bias in Epidemiological Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Factors Affecting Illness
For instance, risk factors are connected to illness,...

